Patents by Inventor Ronghui Lin

Ronghui Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives
    Publication number: 20060173020
    Abstract: 1,2,4-Triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I), pharmaceutically acceptable salts thereof, processes for the manufacture of 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives and pharmaceutical compositions containing 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives are disclosed: The 1,2,4-triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I) possess cell cycle inhibitory activity and are accordingly useful for their anti cell proliferation (such as anti cancer) activity.
    Type: Application
    Filed: October 6, 2005
    Publication date: August 3, 2006
    Inventors: Shenlin Huang, Ronghui Lin, Peter Connolly, Stuart Emanuel, Steven Middleton, Robert Gruninger, Steven Wetter
  • Substituted triazole diamine derivatives as kinase inhibitors
    Publication number: 20050182116
    Abstract: The present invention provides substituted triazole diamine derivatives as selective kinase or dual-kinase inhibitors and a method for treating or ameliorating a selective kinase or dual-kinase mediated disorder.
    Type: Application
    Filed: February 1, 2005
    Publication date: August 18, 2005
    Inventors: Ronghui Lin, Shenlin Huang, Steven Wetter, Peter Connolly, Stuart Emanuel, Robert Gruninger, Steven Middleton
  • Substituted triazole diamine derivatives as kinase inhibitors
    Patent number: 6924302
    Abstract: The present invention provides substituted triazole diamine derivatives as selective kinase or dual-kinase inhibitors and a method for treating or ameliorating a selective kinase or dual-kinase mediated disorder.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: August 2, 2005
    Assignee: Ortho McNeil Pharmaceutical, Inc.
    Inventors: Ronghui Lin, Peter J. Connolly, Steven K. Wetter, Shenlin Huang, Stuart L. Emanuel, Robert H. Gruninger, Steven A. Middleton
  • Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
    Publication number: 20050124610
    Abstract: The present invention provides amino substituted pyridinyl methanone compounds; pharmaceutical compositions comprising the compounds and methods of synthesis thereof. The compounds, which are cyclin dependent kinase (CDK) inhibitors, can be used to treat or ameliorate CDK mediated disorders. The invention thus also provides the therapeutic or prophylactic use of the compounds and/or pharmaceutical compositions to treat such disorders.
    Type: Application
    Filed: November 4, 2004
    Publication date: June 9, 2005
    Inventors: Ronghui Lin, Steven Wetter, Yanhua Lu, Peter Connolly, Stuart Emanuel, Robert Gruninger, Steven Middleton
  • Substituted triazole diamine derivatives as kinase inhibitors
    Publication number: 20040077699
    Abstract: The present invention provides substituted triazole diamine derivatives as selective kinase or dual-kinase inhibitors and a method for treating or ameliorating a selective kinase or dual-kinase mediated disorder.
    Type: Application
    Filed: December 21, 2001
    Publication date: April 22, 2004
    Inventors: Ronghui Lin, Peter J. Connolly, Steven K. Wetter, Shenlin Huang, Stuart L. Emanuel, Robert H. Gruninger, Steve A. Middleton